Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study

BACKGROUND: Concurrent chemoradiotherapy (CCRT) is the standard treatment for limited-stage small-cell lung cancer (LD-SCLC). However, the efficacy of consolidation chemotherapy (CCT) in LD-SCLC remains controversial despite several studies that were performed in the early years of CCT use. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xin-Ru, Liang, Jian-Zhong, Ma, Shu-Xiang, Fang, Wen-Feng, Zhou, Ning-Ning, Liao, Hai, Li, De-Lan, Chen, Li-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036649/
https://www.ncbi.nlm.nih.gov/pubmed/27703372
http://dx.doi.org/10.2147/OTT.S113340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036649/
https://www.ncbi.nlm.nih.gov/pubmed/27703372
http://dx.doi.org/10.2147/OTT.S113340

Ejemplares similares